Cargando…

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

Background: Nearly 3 million people worldwide are coinfected with HIV and HCV. Affordable strategies for prevention are needed. We developed a novel vaccination regimen involving replication-defective and serologically distinct chimpanzee adenovirus (ChAd3, ChAd63) vector priming followed by modifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartnell, Felicity, Brown, Anthony, Capone, Stefania, Kopycinski, Jakub, Bliss, Carly, Makvandi-Nejad, Shokouh, Swadling, Leo, Ghaffari, Emma, Cicconi, Paola, Del Sorbo, Mariarosaria, Sbrocchi, Roberta, Esposito, Ilaria, Vassilev, Ventzislav, Marriott, Paula, Gardiner, Clair M., Bannan, Ciaran, Bergin, Colm, Hoffmann, Matthias, Turner, Bethany, Nicosia, Alfredo, Folgori, Antonella, Hanke, Tomáš, Barnes, Eleanor, Dorrell, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346592/ https://www.ncbi.nlm.nih.gov/pubmed/30713538 http://dx.doi.org/10.3389/fimmu.2018.03175

Ejemplares similares

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
por: Capone, Stefania, et al.
Publicado: (2020)

Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination
por: Woods, Elena, et al.
Publicado: (2021)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure
por: Hartnell, Felicity, et al.
Publicado: (2020)

A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
por: Peruzzi, Daniela, et al.
Publicado: (2009)

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
por: Napolitano, Federico, et al.
Publicado: (2020)

Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man
por: Bolinger, Beatrice, et al.
Publicado: (2015)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
por: Napolitano, Federico, et al.
Publicado: (2021)

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
por: López-Camacho, César, et al.
Publicado: (2018)

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
por: Elsherif, Omar, et al.
Publicado: (2017)

Fatigue following COVID-19 infection is not associated with autonomic dysfunction
por: Townsend, Liam, et al.
Publicado: (2021)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
por: Swadling, Leo, et al.
Publicado: (2016)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes
por: Kelly, Christabel, et al.
Publicado: (2014)

HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction
por: Gargan, Siobhan, et al.
Publicado: (2018)

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
por: Kelly, Christabel, et al.
Publicado: (2016)

Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection
por: Townsend, Liam, et al.
Publicado: (2020)

Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection
por: Townsend, Liam, et al.
Publicado: (2020)

Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
por: Kerstetter, Lucas J., et al.
Publicado: (2021)

LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population
por: Cox, Andrea L, et al.
Publicado: (2019)

Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
por: Natalini, Ambra, et al.
Publicado: (2023)

Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
por: Natalini, Ambra, et al.
Publicado: (2023)

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
por: D’Alise, Anna Morena, et al.
Publicado: (2019)

Antigen‐specific CD8 T cells in cell cycle circulate in the blood after vaccination
por: Simonetti, Sonia, et al.
Publicado: (2019)

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
por: Yang, Xi, et al.
Publicado: (2019)

Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection
por: Liu, Jiaojiao, et al.
Publicado: (2021)

Engineered Viruses as Vaccine Platforms
por: Folgori, Antonella, et al.
Publicado: (2012)

Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8(+) T Cells by Persistent Viruses and Vaccines
por: Gordon, Claire Louse, et al.
Publicado: (2018)

Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
por: Kerr, Colm, et al.
Publicado: (2022)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Adenoviral Producer Cells
por: Kovesdi, Imre, et al.
Publicado: (2010)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques
por: Lorin, Clarisse, et al.
Publicado: (2015)

Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
por: Wang, Xiang, et al.
Publicado: (2017)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
por: Chinnakannan, Senthil K., et al.
Publicado: (2020)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
por: Hayton, Emma-Jo, et al.
Publicado: (2014)

Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
por: Ewer, Katie J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f9elngv6lqu0vc3620uluvgq8b